Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CG Oncology, Inc.COMM(CGON) | 3,670,206 | 3,670,206 | 0 | $89.88M | $95.43M | 10.90% | +$5.54M |
| Tango Therapeutics, Inc.COMM(TNGX) | 10,736,000 | 10,736,000 | 0 | $14.71M | $54.97M | 6.28% | +$40.26M |
| Cogent Biosciences, Inc.COMM(COGT) | 6,964,375 | 6,964,375 | 0 | $41.72M | $50.00M | 5.71% | +$8.29M |
| Ocular Therapeutix, Inc.COMM(OCUL) | 5,319,148 | 5,319,148 | 0 | $38.99M | $49.36M | 5.64% | +$10.37M |
| Cidara Therapeutics IncCOMM | 1,005,901 | 1,005,901 | 0 | $21.67M | $49.00M | 5.60% | +$27.33M |
| ABIVAX Société AnonymeADRS(ABVX) | 6,056,596 | 6,056,596 | 0 | $37.85M | $46.33M | 5.29% | +$8.48M |
| Amylyx Pharmaceuticals, Inc.COMM(AMLX) | 5,943,812 | 5,943,812 | 0 | $21.04M | $38.10M | 4.35% | +$17.06M |
| Centessa Pharmaceuticals PlcADRS | 2,890,816 | 2,890,816 | 0 | $41.57M | $37.99M | 4.34% | -$3.58M |
| Fulcrum Therapeutics, Inc.COMM(FULC) | 5,250,000 | 5,250,000 | 0 | $15.12M | $36.12M | 4.13% | +$21.00M |
| Dyne Therapeutics, Inc.COMM(DYN) | 2,650,150 | 3,766,660 | +1,116,510 | $27.72M | $35.86M | 4.10% | +$8.14M |
| EyePoint, Inc.COMM(EYPT) | 3,572,335 | 3,572,335 | 0 | $19.36M | $33.62M | 3.84% | +$14.25M |
| Upstream Bio, Inc.COMM(UPB) | 2,801,763 | 2,801,763 | 0 | $17.15M | $30.76M | 3.51% | +$13.62M |
| Savara Inc.COMM(SVRA) | 12,362,205 | 12,362,205 | 0 | $34.24M | $28.19M | 3.22% | -$6.06M |
| Dianthus Therapeutics, Inc.COMM(DNTH) | 1,501,624 | 1,501,624 | 0 | $27.24M | $27.98M | 3.20% | +$735.8K |
| Tyra Biosciences, Inc.COMM(TYRA) | 2,898,103 | 2,898,103 | 0 | $26.95M | $27.73M | 3.17% | +$782.5K |
| Disc Medicine, Inc.COMM(IRON) | 465,257 | 465,257 | 0 | $23.10M | $24.64M | 2.81% | +$1.54M |
| Tourmaline Bio IncCOMM | 1,477,593 | 1,477,593 | 0 | $22.47M | $23.63M | 2.70% | +$1.15M |
| Agios Pharmaceuticals, Inc.COMM(AGIO) | 0 | 697,003 | +697,003 | $0 | $23.18M | 2.65% | +$23.18M |
| Structure Therapeutics IncADRS | 1,063,000 | 1,063,000 | 0 | $18.40M | $22.05M | 2.52% | +$3.65M |
| Xencor, Inc.COMM(XNCR) | 2,452,138 | 2,452,138 | 0 | $26.09M | $19.27M | 2.20% | -$6.82M |
| Silence Therapeutics plcADRS(SLN) | 3,033,560 | 3,033,560 | 0 | $8.55M | $17.59M | 2.01% | +$9.04M |
| Soleno Therapeutics IncCOMM | 275,000 | 186,250 | -88,750 | $19.65M | $15.60M | 1.78% | -$4.04M |
| Astria Therapeutics IncCOMM | 2,761,861 | 2,761,861 | 0 | $14.75M | $14.80M | 1.69% | +$55.2K |
| RAPT Therapeutics, Inc.COMM | 0 | 1,636,275 | +1,636,275 | $0 | $13.09M | 1.50% | +$13.09M |
| Third Harmonic Bio IncCOMM | 2,505,424 | 1,915,424 | -590,000 | $8.69M | $10.40M | 1.19% | +$1.71M |
| Enliven Therapeutics, Inc.COMM | 0 | 498,000 | +498,000 | $0 | $9.99M | 1.14% | +$9.99M |
| MBX Biosciences, Inc.COMM(MBX) | 650,000 | 650,000 | 0 | $4.80M | $7.42M | 0.85% | +$2.62M |
| Nektar TherapeuticsCOMM(NKTR) | 0 | 266,666 | +266,666 | $0 | $6.89M | 0.79% | +$6.89M |
| Vistagen Therapeutics, Inc.COMM(VTGN) | 2,676,580 | 2,676,580 | 0 | $6.69M | $5.35M | 0.61% | -$1.34M |
| Kodiak Sciences Inc.COMM(KOD) | 1,145,538 | 1,145,538 | 0 | $3.21M | $4.27M | 0.49% | +$1.06M |
| Kura Oncology, Inc.COMM(KURA) | 1,423,642 | 735,184 | -688,458 | $9.40M | $4.24M | 0.48% | -$5.15M |
| Entrada Therapeutics, Inc.COMM(TRDA) | 584,955 | 584,955 | 0 | $5.29M | $3.93M | 0.45% | -$1.36M |
| Adverum Biotechnologies IncCOMM | 1,796,482 | 1,796,482 | 0 | $7.85M | $3.86M | 0.44% | -$3.99M |
| Avalo Therapeutics, Inc.COMM(AVTX) | 483,000 | 483,000 | 0 | $3.87M | $2.41M | 0.28% | -$1.46M |
| Ventyx Biosciences IncCOMM | 316,195 | 316,195 | 0 | $363.6K | $676.7K | 0.08% | +$313.0K |
| Jade Biosciences IncCOMM | 0 | 64,023 | +64,023 | $0 | $639.6K | 0.07% | +$639.6K |
| Cabaletta Bio, Inc.COMM(CABA) | 86,795 | 86,795 | 0 | $120.2K | $131.9K | 0.02% | +$11.7K |
| Keros Therapeutics, Inc.COMM(KROS) | 0 | 0 | 0 | $0 | $0 | — | $0 |
| Aerovate Therapeutics IncCOMM | 2,240,809 | 0 | -2,240,809 | $5.62M | $0 | — | -$5.62M |
| COMPASS Pathways plcADRS(CMPS) | 3,858,000 | 0 | -3,858,000 | $11.03M | $0 | — | -$11.03M |
| Mineralys Therapeutics, Inc.COMM(MLYS) | 2,470,265 | 0 | -2,470,265 | $39.23M | $0 | — | -$39.23M |
| Nektar TherapeuticsCOMM(NKTR) | 4,000,000 | 0 | -4,000,000 | $2.72M | $0 | — | -$2.72M |
| RAPT Therapeutics, Inc.COMM | 13,090,200 | 0 | -13,090,200 | $15.97M | $0 | — | -$15.97M |